Improving surgical treatment for children with sleep apnea
Optimization of Surgical Treatment for Pediatric Obstructive Sleep Apnea
This study is looking to make surgery for kids with obstructive sleep apnea better by using a special sleep test to understand each child's throat better, so doctors can choose the best way to help them breathe easier during sleep.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10914030 on NIH RePORTER |
What this research studies
This research focuses on optimizing surgical treatment for pediatric obstructive sleep apnea (OSA), a condition affecting 1-4% of children. It aims to personalize the adenotonsillectomy procedure by using drug-induced sleep endoscopy (DISE) to assess each child's unique upper airway anatomy. By determining the best anesthetic agents for the procedure, the research seeks to enhance the accuracy of airway assessments and improve surgical outcomes. The study will gather prospective data to support the use of DISE in guiding individualized surgical interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years diagnosed with obstructive sleep apnea who may require surgical intervention.
Not a fit: Patients who do not have obstructive sleep apnea or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective surgical treatments for children with obstructive sleep apnea, reducing the risk of persistent symptoms and improving overall health outcomes.
How similar studies have performed: While early series have shown promising outcomes with DISE-assisted surgery, this research aims to provide well-controlled, prospective data, making it a novel approach in this area.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Kirkham, Erin Marie — University of Michigan at Ann Arbor
- Study coordinator: Kirkham, Erin Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.